Phase II trial of systemic continuous fluorouracil and subcutaneous recombinant interferon Alfa-2 b for treatment of hepatocellular carcinoma. - Patt,Y.Z.; Hassan,M.M.; Lozano,R.D. (J Clin Oncol, 2003)